Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1995-08-03
1999-03-30
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424450, 564 4, 564 5, 564 8, A61K 5112, A61K 9127, C04F 502
Patent
active
058884734
ABSTRACT:
Boron neutron capture therapy can utilize X.sub.y B.sub.20 H.sub.17 L where X is an alkali metal, y is 1 to 4, and L is a two electron donor such as NH.sub.3, and Na.sub.2 B.sub.10 H.sub.9 NCO, among others. These borane salts may be used free or encapsulated in liposomes. Liposomes may have embedded within their bilayers carboranes to increase the amount of delivered .sup.10 B and/or to increase the tumor specificity of the liposome.
REFERENCES:
patent: 3166378 (1965-01-01), Knoth
patent: 3390966 (1968-07-01), Knoth
patent: 3551120 (1970-12-01), Miller et al.
patent: 4587359 (1986-05-01), Spielvogel
patent: 5328678 (1994-07-01), Fujii et al.
patent: 5649532 (1997-07-01), Hawthorne et al.
Ji Li et al., "Simple Synthesis and Alkylation Reactions of 3-Iodo-O-Carborane and 9,12-Diiodo-O-Carborane," Inorg. Chem., vol. 30, No. 25, pp. 4866-4868, 1991.
M. Frederick Hawthorne et al., "A Study of the Reaction of Hydroxide Ion with B.sub.20 H.sub.18.sup.-2," Journal of the American Chemical Society, 87:21, pp. 4740-4746, Nov. 5, 1965.
Walter R. Hertler, et al., "Chemistry of Boranes XXIV. Carbonylation of Derivatives of B.sub.10 H.sub.10.sup.2- and B.sub.12 H.sub.12.sup.2- with Oxalyl Chloride," Inorganic Chemistry, vol. 4, No. 3, pp. 288-293, Mar. 1965.
Sol M. Gruner et al., "Materials Properties of Liposomal Bilayers," Princeton University, Princeton, New Jersey, 1990.
K. Shelly et al., "Synthesis of Monosubstituted Derivatives of closo-Decahydrodecaborate(2-), X-ray Crystal Structures of NCO!.sup.2-," Inorganic Chemistry, vol. 31, No. 13, 1992, pp. 2889-2892.
C.A. Presant et al., "Preliminary Report: Imaging of Kaposi Sarcoma and Lymphoma in Aids with Indium-111-Labelled Liposomes," The Lancet, vol. 335, pp. 1307-1309, Jun. 2, 1990.
C.A. Presant et al., "Successful Imaging of Human Cancer with Indium-111-Labelled Phospholid Vesicles," Cancer, 62, pp. 905-011, Sep. 1, 1988.
S.M. Sullivan, Lipid Particles for Cytoplasmic Delivery of Active Agent-Esp. Oligo-Nucleotide, Are Liposome(s) Having Succinimidyl GPS. Extending from Surface, Abstract (Basic): WO 9205773 A.
F.C. Szoka et al., "Liposome Compsn.--Congt. Encapsulated Antiviral Cpd., E.g. Phosophono-Acetate or Phosphono-Formate, Used to Treat HV and Herpes Simplex Virus-2 Infections," Abstract (Basic), WO 8905152.
C.A. Presant et al., "Liposome(s) for Delivering Imaging Agent or Drug to Tumour Comprising Small Liposome(s) Prepd. from Pure Phospholipid," Abstract (Basic): EP 179444.
H. Hatanaka, "Boron-Neutron Capture Therapy for Tumors," 1986.
M.F. Hawthorne et al., "The Preparation of B.sub.10 H.sub.10.sup.2- Ion," vol. IX, Inorgnaic Synthesis, ed. by S. Young Tyree, Jr., McGraw-Hill Publishing Co., Inc., 1967. and liposome delivery to murine tumors, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 3029-3033, Apr. 1994.
K. Shelly et al., "Model studies directed toward the boron neutron-capture therapy by cancer: Boron delivery to murine tumors with liposomes," Proc. Natl. Acad. Sci. U.S.A., vol. 89, pp. 9039-9043, Oct. 1992.
K.C. John et al., The Aklylation and Acylation of B.sub.10 H.sub.9 NH.sub.3.sup.-, J. Med. Chem., vol. 12, pp. 54-57, Jan. 1969.
Feakes Debra Arliene
Hawthorne M. Frederick
Shelly Kenneth John
Hartley Michael G.
Hollinden Gary E.
The Regents of the University of California
LandOfFree
Liposome compositions for boron neutron capture therapy and meth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposome compositions for boron neutron capture therapy and meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome compositions for boron neutron capture therapy and meth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1211493